Summary
47 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $575.0M in the last fiscal year, 17% of its market value.
- Out of every 100 USD of revenue, 21 USD is left as free cash.
- Analysts expect revenue to grow by 13% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 15% a year over 5 years. Over the last 3 years it grew by 13% a year. For the next fiscal year analysts expect revenue to grow by 13%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $174.6M.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 26
- Hold 14
- Sell 1
Today's price within the analysts' price targets
The average target of $77.83 is 3.3% below today's price. 63% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Creative Subscription 71%
- Business Solutions 29%
By region
- UNITED STATES 56%
- Europe 25%
- Other 18%
- ISRAEL 0.9%
Creative Subscription brings in 71% of revenue.
Segments in detail